UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Journal of clinical oncology, 2004-01, Vol.22 (1), p.53-61

2004

Volltextzugriff (PDF)

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

European journal of cancer (1990), 2018-01, Vol.88, p.1-9

2018

Volltextzugriff (PDF)

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-01, Vol.33 (1), p.e54-e57

2021

Volltextzugriff (PDF)

Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial

Lung cancer (Amsterdam, Netherlands), 2010, Vol.67, p.S10-S11

2010

Volltextzugriff (PDF)

Omitting elective nodal irradiation (ENI) during thoracic irradiation in limited-stage small cell lung cancer (LS-SCLC) Patterns of failure from a phase II trial

Lung cancer (Amsterdam, Netherlands), 2010, Vol.67, p.S10-S10

2010

Volltextzugriff (PDF)

Prophylactic cranial irradiation (PCI) in extensive disease (ED) small cell lung cancer (SCLC): an audit of practice

Lung cancer (Amsterdam, Netherlands), 2008, Vol.60, p.S4-S4

2008

Volltextzugriff (PDF)

1058P Treatment outcomes with unselected autologous tumor infiltrating lymphocytes (TILs) in patients (pts) with checkpoint inhibition–refractory advanced cutaneous melanoma

Annals of oncology, 2021-09, Vol.32, p.S882-S882

2021

Volltextzugriff (PDF)

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

Annals of oncology, 2017-10, Vol.28 (10), p.2581-2587

2017

Volltextzugriff (PDF)

Characteristics of Women with Recurrent Molar Pregnancies

Gynecologic oncology, 2000-09, Vol.78 (3), p.288-292

2000

Volltextzugriff (PDF)

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 1999-03, Vol.35 (3), p.410-412

1999

Volltextzugriff (PDF)

Tumour lysis syndrome, case report and review of the literature

Annals of oncology, 1996-08, Vol.7 (6), p.631-636

1996

Volltextzugriff (PDF)

The vedex regimen: An effective and well tolerated palliative treatment for non-Hodgkin's lymphoma (NHL)

European journal of cancer (1990), 1997-09, Vol.33, p.S266-S266

1997

Volltextzugriff (PDF)

Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA

Cancer letters, 1996-06, Vol.104 (1), p.27-30

1996

Volltextzugriff (PDF)

1168 Etoposide and actinomycin D (EA) for methotrexate (MTX) resistant, low risk, persistent gestational trophoblastic disease (GTD) and EA with MTX (MEA) for high risk GTD

European journal of cancer (1990), 1995-11, Vol.31, p.S244-S244

1995

Volltextzugriff (PDF)

This letter was referred to the authors, who respond as follows

Annals of oncology, 1997-01, Vol.8 (1), p.97-97

1997

Volltextzugriff (PDF)

Corrigenda

Annals of oncology, 1997-04, Vol.8 (4), p.407

1997

Volltextzugriff (PDF)

Corrigenda

Annals of oncology, 1997-04, Vol.8 (4), p.407-407

1997

Volltextzugriff (PDF)

Small cell carcinoma of the cervix

Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Vol.8 (2), p.102-105

1996

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Adult
(7)
Female
(7)
Life Sciences & Biomedicine
(7)
Oncology
(7)
Science & Technology
(7)
Male
(6)
Adolescent
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Aged
(4)
Middle Aged
(4)
Treatment Outcome
(4)
Tumors
(4)
Aged, 80 And Over
(3)
Gynecology. Andrology. Obstetrics
(3)
Hematology, Oncology And Palliative Medicine
(3)
Pulmonary/respiratory
(3)
Age Factors
(2)
Antineoplastic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial

Omitting elective nodal irradiation (ENI) during thoracic irradiation in limited-stage small cell lung cancer (LS-SCLC) Patterns of failure from a phase II trial

Prophylactic cranial irradiation (PCI) in extensive disease (ED) small cell lung cancer (SCLC): an audit of practice

1058P Treatment outcomes with unselected autologous tumor infiltrating lymphocytes (TILs) in patients (pts) with checkpoint inhibition–refractory advanced cutaneous melanoma

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

Characteristics of Women with Recurrent Molar Pregnancies

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Tumour lysis syndrome, case report and review of the literature

The vedex regimen: An effective and well tolerated palliative treatment for non-Hodgkin's lymphoma (NHL)

Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA

1168 Etoposide and actinomycin D (EA) for methotrexate (MTX) resistant, low risk, persistent gestational trophoblastic disease (GTD) and EA with MTX (MEA) for high risk GTD

This letter was referred to the authors, who respond as follows

Corrigenda

Corrigenda

Small cell carcinoma of the cervix

Suchergebnisse filtern